doc. Mgr. Martin Trbušek, Dr.

2014

• Is checkpoint kinase 1 a suitable molecular target for combination with cancer chemotherapeutics?

  ZEMANOVÁ Jana ŠEBEJOVÁ Ludmila HYLSE Ondřej PARUCH Kamil POSPÍŠILOVÁ Šárka TRBUŠEK Martin

  Conference abstract

  Year: 2014, type: Conference abstract

• Is checkpoint kinase 1 a suitable molecular target for sensitization of TP53-mutated leukemia and lymphoma cells to chemotherapy?

  ZEMANOVÁ Jana ŠEBEJOVÁ Ludmila HYLSE Ondřej PARUCH Kamil POSPÍŠILOVÁ Šárka TRBUŠEK Martin

  Conference abstract

  Year: 2014, type: Conference abstract

• Molekulární prognostické markery chronické lymfocytární leukemie a význam sekvenování nové generace při studiu patogeneze onemocnění

  KANTOROVÁ Barbara NAVRKALOVÁ Veronika TICHÝ Boris MALČÍKOVÁ Jitka TOM Nikola PÁL Karol STAŇO KOZUBÍK Kateřina TAKÁČOVÁ Sylvia PLEVOVÁ Karla TRBUŠEK Martin BRYCHTOVÁ Yvona DOUBEK Michael MAYER Jiří POSPÍŠILOVÁ Šárka

  Conference abstract

  Year: 2014, type: Conference abstract

• New carbocyclic nucleosides: synthesis of carbocyclic pseudoisocytidine and its analogs

  MAIER Lukáš HYLSE Ondřej NEČAS Marek TRBUŠEK Martin YTRE-ARNE Mari DALHUS Bjorn BJORAS Magnar PARUCH Kamil

  Article in Periodical

  Tetrahedron Letters, year: 2014, volume: 55, edition: 27, DOI

• NOD/SCID gamma xenograft model of B-cell malignancies using TP53- and/or ATM-deficient cell lines

  VERNER Jan TRBUŠEK Martin CHOVANCOVÁ Jana ŠKABRAHOVÁ Hana MOULIS Mojmír FOLBER František HALOUZKA R MAYER Jiří POSPÍŠILOVÁ Šárka DOUBEK Michael

  Conference abstract

  Year: 2014, type: Conference abstract

• Prognostic impact of NOTCH1 hotspot mutation in TP53-mutated patients with chronic lymphocytic leukemia

  KANTOROVÁ Barbara MALČÍKOVÁ Jitka NAVRKALOVÁ Veronika ŠMARDOVÁ Jana BRÁZDILOVÁ Kamila PLEVOVÁ Karla DIVÍŠKOVÁ Eva BORSKÝ Marek PAVLOVÁ Šárka TOM Nikola PÁL Karol TRBUŠEK Martin OLTOVÁ Alexandra BRYCHTOVÁ Yvona DOUBEK Michael MAYER Jiří POSPÍŠILOVÁ Šárka

  Conference abstract

  Year: 2014, type: Conference abstract

• Reactivation of mutated p53 in chronic lymphocytic leukemia cells using prima-1 met.

  JAŠKOVÁ Zuzana ŠEBEJOVÁ Ludmila BRYCHTOVÁ Yvona DOUBEK Michael POSPÍŠILOVÁ Šárka TRBUŠEK Martin

  Conference abstract

  Year: 2014, type: Conference abstract

• SF3B1 mutations in CLL are associated with a defective DNA damage response

  ELDERING E. TE RAA D. DERKS I. NAVRKALOVÁ Veronika SKOWRONSKA A. OLDREIVE C. MOERLAND P. MALČÍKOVÁ Jitka TRBUŠEK Martin HULLEIN J. JETHWA A. ZENZ T. POSPÍŠILOVÁ Šárka STANKOVIC T. VAN OERS M. KATER A.

  Conference abstract

  Year: 2014, type: Conference abstract

• Targeted next-generation sequencing for mutational screening in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation within a clinical setting

  SUTTON LA. LJUNGSTROM V. MANSOURI E. YOUNG E. CORTESE D. NAVRKALOVÁ Veronika MALČÍKOVÁ Jitka MUGGEN F. TRBUŠEK Martin DAVI F. BELESSI C. LANGERAK W. GHIA P. POSPÍŠILOVÁ Šárka STAMATOPOULOS K. ROSENQUIST R.

  Conference abstract

  Year: 2014, type: Conference abstract

• The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors

  MALČÍKOVÁ Jitka STALIKA Evangelia DAVIS Zadie PLEVOVÁ Karla TRBUŠEK Martin MANSOURI Larry SCARFO Lydia BALIAKAS Panagiotis GARDINER Anne SUTTON LA FRANCOVA Hana Skuhrová AGATHANGELIDIS Andreas ANAGNOSTOPOULOS Achilles TRACY Ian MAKRIS Antonis ŠMARDOVÁ Jana GHIA Paolo BELESSI Chrysoula GONZALEZ David ROSENQUIST Richard OSCIER David POSPÍŠILOVÁ Šárka STAMATOPOULOS Kostas

  Article in Periodical

  British Journal of Haematology, year: 2014, volume: 166, edition: 4, DOI